What happened
According to an SEC filing dated May 15, 2026, Rubicon Founders LLC increased its holdings in Privia Health Group (PRVA 0.37%) by 175,142 shares during the first quarter. The estimated transaction value was $3.95 million, calculated using the average closing prices for the quarter. The quarter-end value of the position fell by $14.53 million, a figure that reflects both the trading activity and changes in share price.
What else to know
- Rubicon Founders’ post-trade position in Privia Health Group means the stock now represents 88.92% of 13F reportable AUM.
- Top holdings after the filing:
- NASDAQ: PRVA: $122.36 million (88.92% of AUM)
- NYSE: EVH: $13.26 million (9.64% of AUM)
- NYSE: AGL: $1.99 million (1.45% of AUM)
- As of May 14, 2026, shares of Privia Health Group were priced at $23.24, down 4.4% over the past year, trailing the S&P 500 by 31.66 percentage points.
Company overview
| Metric | Value |
|---|---|
| Revenue (TTM) | $2.25 billion |
| Net income (TTM) | $21.76 million |
| Market capitalization | $2.94 billion |
| Price (as of market close May 14, 2026) | $23.24 |
Company snapshot
- Privia Health Group offers technology solutions, population health tools, and management services to optimize physician practices and enhance patient care, generating revenue primarily from physician enablement and value-based care services.
- It operates a physician-enablement platform and management services organization that facilitates clinical integration, payer negotiations, and administrative support, monetizing through service fees and value-based contracts.
- The company serves independent providers, medical groups, health plans, and health systems across the United States, targeting healthcare organizations seeking efficiency and improved patient outcomes.
Privia Health Group is a national healthcare platform specializing in physician enablement and value-based care solutions. The company leverages technology and coordinated care models to support independent providers and medical groups, driving operational efficiency and improved patient experiences.
With a scalable business model and a focus on aligning financial incentives, Privia Health positions itself as a strategic partner for healthcare organizations navigating the shift to value-based care.
What this transaction means for investors
Rubicon Founders increasing its stake in Privia Health Group during the first quarter is a noteworthy event for investors. It demonstrates the hedge fund has a bullish outlook towards the stock, so much so that Privia Health now represents nearly 90% of the firm’s AUM. As a result, the fund’s performance depends almost entirely on this one stock.
A deeper look into Privia Health Group’s financials reveals a strong company. It ended 2025 with $2.1 billion in revenue, up an impressive 22% year over year. Its 2025 net income rose 59% over 2024 to $22.9 million. Its balance sheet was outstanding with $1.4 billion in total assets compared to $578.4 million in total liabilities and no debt.
The company followed 2025 with accelerating sales in the first quarter of 2026. Revenue rose 26% year over year to $603.8 million, and Privia Health expects full-year revenue to reach around $2.4 billion.
This performance suggests customers are finding its solutions are fulfilling an unmet need in the healthcare industry, and bodes well for Privia Health’s ongoing success. Consequently, its stock looks like a worthwhile long-term investment.
Robert Izquierdo has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
